Akebia Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.63
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.15
|
-0.28
|
-0.13
|
-86.67%
|
|
2022-06-30
|
-0.31
|
0.15
|
0.46
|
148.39%
|
|
2022-03-31
|
-0.29
|
-0.35
|
-0.06
|
-20.69%
|
|
2021-12-31
|
-0.33
|
-0.40
|
-0.07
|
-21.21%
|
|
2021-09-30
|
-0.32
|
-0.34
|
-0.02
|
-6.25%
|
|
2021-06-30
|
-0.32
|
-0.51
|
-0.19
|
-59.38%
|
|
2021-03-31
|
-0.29
|
-0.45
|
-0.16
|
-55.17%
|
|
2020-12-31
|
-0.40
|
-0.60
|
-0.20
|
-50.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.48
|
|
2021-12-31
|
-1.70
|
|
2020-12-31
|
-2.77
|
|
2019-12-31
|
-2.36
|
|
2018-12-31
|
-1.77
|
|
2017-12-31
|
-1.92
|
|
2016-12-31
|
-3.60
|
|
2015-12-31
|
-2.27
|
|
2014-12-31
|
-5.73
|